Companies: 10,795·Total market cap: $144.5T
Cigna Corporation

Cigna Corporation

CINYSEHealthcare● Active
$288.45
$-1.04(-0.36%)
Market Cap$76.3B
P/E Ratio
52W High$338.89
52W Low$239.51

Cigna Corporation (CI) Free Cash Flow & Analysis

Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.

CI · free cash flow · updated Jun 8, 2026

Core FCF metrics

Free cash flow was $8.39B for FY2025 (fiscal year ending 2025-12-31), down 6.3% year-over-year The FCF margin was 3.0%. Five-year CAGR stands at -1.9%.

FY2025 Free Cash Flow$8.39B▼ -6.3% YoY
Trailing 12M (TTM)$7.66Btrailing 4 quarters sum
FCF Margin3.0%$8.39B ÷ revenue
3-Year CAGR+4.5%FY2022 → FY2025
5-Year CAGR-1.9%FY2020 → FY2025
FormulaFCF = Operating Cash Flow − Capital ExpendituresTTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0
Source: FMP /cash-flow-statement · SEC 10-K / 10-Q · USDUpdated: Jun 8, 2026

Annual free cash flow history

Positive FCFNegative FCF
Free Cash Flow
YoY Growth %
ci free cash flow history · ci free cash flow chart · ci free cash flow growth rate · ci free cash flow last 10 years

Annual free cash flow data

Fiscal YearFree Cash FlowYoY ChangeFCF Margin
FY2025Latest$8.39B▼ 6.3%3.0%
FY2024$8.96B▼ 12.5%3.6%
FY2023$10.24B▲ +39.1%5.2%
FY2022$7.36B▲ +21.9%4.1%
FY2021$6.04B▼ 34.8%3.5%
FCF = Operating Cash Flow − Capital Expenditures · CapEx shown as (negative) · Source: SEC filings via FMP
ci free cash flow 2025 · ci free cash flow 2024 · ci free cash flow 2023 · ci operating cash flow

FCF valuation metrics

Cigna Corporation (CI) trades at a FCF yield of 10.02% and a price-to-free-cash-flow ratio of 10.0x. FCF per share stands at $28.80, calculated using trailing twelve-month FCF divided by basic weighted-average shares outstanding.

FCF Yield (TTM)
10.02%
Free Cash Flow ÷ Market Cap
per FMP freeCashFlowYieldTTM definition
FCF per Share (TTM)
$28.80
TTM FCF ÷ Shares Outstanding
Price / FCF
x10.0
Share Price ÷ FCF per Share
EV / FCF (TTM)
x13.1
Enterprise Value basis
Source: FMP /key-metrics-ttm · /cash-flow-statement Q · /income-statementFY2025 · 2025-12-31
ci price to free cash flow · ci free cash flow yield · ci free cash flow per share · ci price to cash flow ratio

Cash flow statement summary

For FY2025, Cigna Corporation generated $9.60B in operating cash flow and spent 1.21B in capital expenditures, yielding $8.39B in free cash flow.

Operating Activities
+$9.60B
Cash from core business operations
2025-12-31
Investing Activities
−$4.41B
CapEx, acquisitions & investments
2025-12-31
Financing Activities
−$6.42B
Buybacks, dividends & debt
2025-12-31
FCF FormulaOperating CF ($9.60B) − |CapEx| (1.21B) = FCF ($8.39B)

For the complete Operating / Investing / Financing line-item breakdown:

View Full Cash Flow Statement
ci cash flow statement · ci cash flow statement 2025 · ci operating cash flow · ci cash flow from operations

Free cash flow vs peers (Healthcare)

#CompanyFree Cash FlowYoY
#1
Cigna Corporation
Cigna CorporationYOU
CI
$8.39B-6.3%
#2
Johnson & Johnson
Johnson & Johnson
JNJ
$19.70B-0.7%
#3
AbbVie Inc.
AbbVie Inc.
ABBV
$17.82B-0.1%
#4
UnitedHealth Group Incorporated
UnitedHealth Group Incorporated
UNH
$16.07B-22.4%
#5
Eli Lilly and Company
Eli Lilly and Company
LLY
$8.97B+2065.6%
Healthcare · Sorted by FCF · FMP /cash-flow-statementFull FCF Rankings →

About Free Cash Flow & Methodology

Cigna Corporation (CI) reported free cash flow of $8.39B for FY2025 (fiscal year ending 2025-12-31), down 6.3% year-over-year. The FCF margin was 3.0%.

Based on available data, Cigna Corporation has maintained positive free cash flow for at least 15 fiscal year(s). FCF peaked at $10.24B in FY2023. The 5-year CAGR stands at -1.9%.

Cigna Corporation's FCF yield is 10.02% and price-to-FCF ratio is 10.0x for FY2025, based on the latest available data.

Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.

Q&A and summaries align with SEC 10-K/10-Q cash flow disclosures and FMP /cash-flow-statement where noted.

Frequently asked questions

CI free cash flow · 8 questions

Cigna Corporation free cash flow was $8.39B for FY2025, down 6.3% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at $7.66B.

CI free cash flowCI FCFCI FCF 2025CI free cash flow TTM

Source: FMP /cash-flow-statement · US GAAP · Cigna Corporation · Cigna Corporation SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026